Search research articles
Contact Us
Filters
Showing results (211-220 of 240) with videos related to
Page
of 24
Sort By:
The New England Journal of Medicine
|
June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
European Journal of Heart Failure
|
June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC
Gabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
Journal of the American College of Cardiology
|
November 30, 2019
Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial
David A Wood, John A Cairns, Jia Wang, et al.
European Journal of Heart Failure
|
March 17, 2025
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC
Davide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
American Heart Journal
|
August 30, 2024
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
Sneha S Jain, Kenneth W Mahaffey, Karen S Pieper, et al.
European Heart Journal
|
May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
Jackie Bosch, Eva M Lonn, Hyejung Jung, et al.
European Journal of Heart Failure
|
May 27, 2019
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology
Petar M Seferovic, Piotr Ponikowski, Stefan D Anker, et al.
The New England Journal of Medicine
|
April 5, 2016
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Salim Yusuf, Eva Lonn, Prem Pais, et al.
The New England Journal of Medicine
|
April 5, 2016
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Salim Yusuf, Jackie Bosch, Gilles Dagenais, et al.
European Heart Journal
|
September 2, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
C Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 240) with videos related to
Sort By:
Page
of 24
The New England Journal of Medicine
|
June 4, 2015
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P Cannon, Michael A Blazing, Robert P Giugliano, et al.
European Journal of Heart Failure
|
June 16, 2025
The crosstalk between immune activation and metabolism in heart failure. A scientific statement of the Heart Failure Association of the ESC
Gabriele Fragasso, Davide Stolfo, Markus S Anker, et al.
Journal of the American College of Cardiology
|
November 30, 2019
Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial
David A Wood, John A Cairns, Jia Wang, et al.
European Journal of Heart Failure
|
March 17, 2025
How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC
Davide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, et al.
American Heart Journal
|
August 30, 2024
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
Sneha S Jain, Kenneth W Mahaffey, Karen S Pieper, et al.
European Heart Journal
|
May 8, 2021
Lowering cholesterol, blood pressure, or both to prevent cardiovascular events: results of 8.7 years of follow-up of Heart Outcomes Evaluation Prevention (HOPE)-3 study participants
Jackie Bosch, Eva M Lonn, Hyejung Jung, et al.
European Journal of Heart Failure
|
May 27, 2019
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology
Petar M Seferovic, Piotr Ponikowski, Stefan D Anker, et al.
The New England Journal of Medicine
|
April 5, 2016
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease
Salim Yusuf, Eva Lonn, Prem Pais, et al.
The New England Journal of Medicine
|
April 5, 2016
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
Salim Yusuf, Jackie Bosch, Gilles Dagenais, et al.
European Heart Journal
|
September 2, 2024
Apolipoprotein A-I infusions and cardiovascular outcomes in acute myocardial infarction according to baseline LDL-cholesterol levels: the AEGIS-II trial
C Michael Gibson, Danielle Duffy, Maria Cecilia Bahit, et al.
Page
of 24